Stock VRDN VIRIDIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Real-time Estimate Cboe BZX
Other stock markets
 02:17:39 2024-04-29 pm EDT 		5-day change 1st Jan Change
13.25 USD +2.87% Intraday chart for Viridian Therapeutics, Inc. -6.43% -38.57%
Apr. 16 Foghorn Therapeutics Names Kristian Humer CFO MT
Mar. 21 B. Riley Lowers Viridian Therapeutics' PT to $25 From $29, Keeps Buy Rating; Adjusts Model to Reflect Recent Equity Offering, Quarterly Numbers MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VRDN Stock
  4. News Viridian Therapeutics, Inc.
  5. MarketScreener Editorial Features